계명대학교 의학도서관 Repository

The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE) in patients with advanced solid cancers receiving anticoagulation therapy after the diagnosis of index VTE

Metadata Downloads
Author(s)
Ho-Young YhimMoon Ju JangJae-Yong KwakChang-Yeol YimWon-Il ChoiYong Cheol LeeJeong-Ok LeeKeun-Wook LeeSoo-Mee BangSung-Hyun KimYeo-Kyeoung KimHye Jung ChangDoyeun Ohthe Korean Venous Thromboembolism Working Party
Keimyung Author(s)
Choi, Won IlLee, Yong Cheol
Department
Dept. of Internal Medicine (내과학)
Dept. of Anesthesiology & Pain Medicine (마취통증의학)
Journal Title
Thrombosis Research
Issued Date
2013
Volume
131
Issue
4
Keyword
Venous thromboembolismDeep vein thrombosisCancerRecurrenceSurvival
Abstract
Patients with cancer have been associated with increased risk of recurrent venous thromboembolism (VTE). However, data on recurrent VTE in Asian patients with advanced solid cancers are limited.

Methods

This study was conducted using data from the Korean VTE registry, which is an ongoing, prospective database. Patients were eligible if they had diagnosed with recurrent/metastatic solid cancers and initiated anticoagulation therapy following index VTE diagnosis. A total of 449 patients were included in this analysis. The 6-month and 12-month cumulative incidences of recurrent VTE were 20.6% and 27.0%, respectively. Isolated pulmonary embolism (PE) (51%) was the most predominant recurrence type. Pancreas as the primary tumor site, poor Eastern Cooperative Oncology Group performance status at the time of index VTE diagnosis, and initial presentation with PE were independent risk factors for developing recurrent VTE. With a median follow-up of 29.1 months (range, 1.0-91.2), the median overall survival (OS) was 11.9 months. Patients with recurrent VTE had a significantly worse OS than those without recurrent VTE (median, 8.4 vs. 13.0 months, respectively; P = 0.001). In conclusion, the incidence of recurrent VTE in Korean patients with advanced solid cancers is comparable with Caucasian patients. Pancreas as the primary tumor site, poor performance status, and initial presentation with PE are independent recurrent VTE risk factors in advanced cancer VTE patients. Additionally, OS is adversely affected by recurrent VTE.

Keywords
Venous thromboembolism;
Deep vein thrombosis;
Cancer;
Recurrence;
Survival
Keimyung Author(s)(Kor)
최원일
이용철
Publisher
School of Medicine
Citation
Ho-Young Yhim et al. (2013). The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE)
in patients with advanced solid cancers receiving anticoagulation therapy after the diagnosis of index VTE. Thrombosis Research, 131(4), e133–e140. doi: 10.1016/j.thromres.2013.01.025
Type
Article
ISSN
0049-3848
Source
https://www.sciencedirect.com/science/article/pii/S0049384813000303?via%3Dihub
DOI
10.1016/j.thromres.2013.01.025
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/34653
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Anesthesiology & Pain Medicine (마취통증의학)
1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
공개 및 라이선스
  • 공개 구분공개
  • 엠바고Forever
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.